FGFR2 FUSIONS

Clinical trials for FGFR2 FUSIONS explained in plain language.

Never miss a new study

Get alerted when new FGFR2 FUSIONS trials appear

Sign up with your email to follow new studies for FGFR2 FUSIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for bile duct cancer: targeted drug shows promise in phase 2 trial

Disease control Recruiting now

This study tests two different doses (20 mg and 16 mg) of the drug futibatinib in people with advanced bile duct cancer that has a specific genetic change (FGFR2 fusion or rearrangement). About 120 participants who have already received chemotherapy will take the drug daily to se…

Matched conditions: FGFR2 FUSIONS

Phase: PHASE2 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control

Last updated May 17, 2026 04:11 UTC

FGFR2 FUSIONS

Get alerted when new FGFR2 FUSIONS trials appear

New hope for bile duct cancer: targeted drug shows promise in phase 2 trial